TGFB1 and neoplasm: MSCs, often reprogrammed in tumors, may secrete immunosuppressive factors such as IL-10 and TGF-β, with EVs potentially enhancing this effect by delivering specific miRNAs or proteins that boost MSC immunosuppressive functions, thus facilitating tumor immune evasion (102).